[go: up one dir, main page]

AU1801299A - Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow - Google Patents

Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow

Info

Publication number
AU1801299A
AU1801299A AU18012/99A AU1801299A AU1801299A AU 1801299 A AU1801299 A AU 1801299A AU 18012/99 A AU18012/99 A AU 18012/99A AU 1801299 A AU1801299 A AU 1801299A AU 1801299 A AU1801299 A AU 1801299A
Authority
AU
Australia
Prior art keywords
brinzolamide
medicament
manufacture
blood flow
ocular blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18012/99A
Inventor
George Barnes
Michael L. Chandler
Thomas R. Dean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU1801299A publication Critical patent/AU1801299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU18012/99A 1997-12-12 1998-12-01 Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow Abandoned AU1801299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6965697P 1997-12-12 1997-12-12
US60069656 1997-12-12
PCT/US1998/025481 WO1999030717A1 (en) 1997-12-12 1998-12-01 Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow

Publications (1)

Publication Number Publication Date
AU1801299A true AU1801299A (en) 1999-07-05

Family

ID=22090398

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18012/99A Abandoned AU1801299A (en) 1997-12-12 1998-12-01 Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow

Country Status (4)

Country Link
AR (1) AR015494A1 (en)
AU (1) AU1801299A (en)
WO (1) WO1999030717A1 (en)
ZA (1) ZA9811387B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753009B2 (en) 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5789435A (en) * 1995-05-22 1998-08-04 Advanced Research And Technology Institute Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight

Also Published As

Publication number Publication date
AR015494A1 (en) 2001-05-02
ZA9811387B (en) 1999-07-14
WO1999030717A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU6639096A (en) Corneal irrigation cannula
ZA966319B (en) Corneal irrigation cannula
AU5732699A (en) Corneal onlay
AU7005694A (en) Use of hydrophilic carotenoids for the manufacture of a medicament for the treatment of diseases having an oxygenation mechanism
AU1704499A (en) Active blood filter
AU9083098A (en) Diagnosis of ocular pathogens
AU3560495A (en) Medicament inhaler
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
AU2039800A (en) 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
AU5264296A (en) Disposable oral suction tip
AU7700596A (en) Disposable scalpel
AU1729795A (en) Miniature disposable blood flow monitor
AU3968695A (en) Patient operated tonometers
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
AU7982098A (en) Use of beta2-adrenoceptor agonists for the manufacture of a medicament for the treatment of scoliosis
AU2748895A (en) Medical nebuliser
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU1801299A (en) Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU3071799A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection
AU1405001A (en) Treatment of diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase